ICAM1 and Stroke: Of interest, the administration of ICAM-1 antibodies showed a reduction of the ischemic area only animal models of stroke with transient ischemia [51], while no effect was found in permanent ischemia models [52], highlighting the important role of leukocyte infiltration during ischemia/reperfusion injury.